术前TACE对可切除大肝癌术后无瘤生存率及生存率的影响

目的 分析术前经导管肝动脉化疗栓塞(TACE)对可切除大肝癌术后无瘤生存率及总生存率的影响,探讨可切除大肝癌术前TACE意义. 方法 108例大肝癌病例分成术前TACE组(n=52)与一期手术组(n=56),进行随访,并根据有无肉眼子灶、癌栓分组对照作生存分析. 结果 二期手术组与一期手术组无瘤生存率及总生存率差异无统计学意义. 结论可切除大肝癌术前TACE并未能提高无瘤生存率及总生存率,应首选手术治疗.

Influence of preoperative transcatheter arterial chemoembolization on disease-free survival rates and overall suvival rates in patients with resectable large hepatocellular carcinoma

Objective To investigate influence and significance of preoperative transcatheter arterial chemoembolization (TACE) on disease-free survival rates and overall suvival rates in patients with respectable large hepatocellular carcinoma(HCC). Methods One hundred and eight patients with respectable large primary liver cancers were prospectively randomized into two groups: preoperative TACE group(n=52) and one-stage operation group(n=56). We compared between two groups according to daughter nodules and tumor thrombus. Results There were no significant differences in the incidence of disease-free survival rates and overall suvival rates in the two groups. Conclusion Preoperative TACE for resectable large HCC should be used on bases of strict selection because it does not decrease the recrudescence rates and results in delayed surgery in some cases.